Curs BNR — 12.11.2026 EUR 5,3459 USD 4,8155 GBP 6,3935

BIOFARM

96 articole · RSS

Biofarm Seeks To Pay Out RON30.5M Worth Of Dividends From 2023 Profit
Companies

Biofarm Seeks To Pay Out RON30.5M Worth Of Dividends From 2023 Profit

Pharmaceutical producer Biofarm Bucuresti (BIO.RO) has called shareholders to approve, among others, the distribution of RON30.5 million dividends from 2023 net profit.

Ecaterina Craciun · 20.03.2024 · 23:22 · 1 min
Biofarm Plans to Expand Further Abroad
Companies

Biofarm Plans to Expand Further Abroad

Biofarm, a top five drug manufacturer locally, plans to expand on other foreign markets, both in and outside Europe.

Georgiana Mihalache · 18.12.2023 · 09:44 · 1 min
Biofarm's Sales Income Up 9.7% YoY To RON229M In January-September 2023
Companies

Biofarm's Sales Income Up 9.7% YoY To RON229M In January-September 2023

Pharmaceutical producer Biofarm Bucuresti (BIO.RO) announced in its financial report released on Nov 14 that its sales income grew by 9.7% on the year to RON229 million in the first nine mon...

Ecaterina Craciun · 14.11.2023 · 21:36 · 1 min
Biofarm Shareholders Approve Sale Of EUR5M Property In Capital Bucharest
Health

Biofarm Shareholders Approve Sale Of EUR5M Property In Capital Bucharest

Pharmaceutical producer Biofarm Bucuresti (BIO.RO) has informed the local capital market in a report about the decisions taken at the Extraordinary General Meeting of Shareholders of October...

Ecaterina Craciun · 05.10.2023 · 22:52 · 1 min
Biofarm Sells Land Plot To Iancu de Hunedoara Residence SRL For Nearly EUR5M
Real Estate

Biofarm Sells Land Plot To Iancu de Hunedoara Residence SRL For Nearly EUR5M

Pharmaceutical producer Biofarm Bucuresti (BIO.RO) has sold a plot of land to the company Iancu de Hunedoara Residence SRL for approximately EUR5 million.

Ecaterina Craciun · 12.09.2023 · 22:50 · 1 min
Biofarm Ends H1/2023 With RON50M Profit, Up 15% YoY
Health

Biofarm Ends H1/2023 With RON50M Profit, Up 15% YoY

Pharmaceutical producer Biofarm Bucuresti (BIO.RO) reported a profit of RON50.1 million for January-June 2023, up 15% from RON43.6 million reported for the same period of 2022.

Ecaterina Craciun · 12.08.2023 · 00:51 · 1 min
Biofarm Eyes Nearly RON325M Turnover In 2023, Up 17% Vs 2022
Companies

Biofarm Eyes Nearly RON325M Turnover In 2023, Up 17% Vs 2022

Pharmaceutical producer Biofarm Bucuresti (BIO.RO) estimates a turnover of approximately RON325 million for 2023, up 17% versus 2022 level, and a 6% higher net profit compared to 2022 when i...

Ecaterina Craciun · 11.05.2023 · 15:36 · 1 min
Biofarm Estimates RON325M Revenue In 2023, Up 17% From 2022
Companies

Biofarm Estimates RON325M Revenue In 2023, Up 17% From 2022

Pharmaceutical producer Biofarm Bucuresti (BIO.RO), the fifth largest drug producer in Romania, has budgeted revenue of RON325 million for 2023, which translates into a 17% increase compared...

Ecaterina Craciun · 10.04.2023 · 14:41 · 1 min
Biofarm Proposes Shareholders RON29.7M Dividends from 2022 Profit
Capital Market

Biofarm Proposes Shareholders RON29.7M Dividends from 2022 Profit

Pharmaceutical producer Biofarm (BIO.RO) has called shareholders for April 26, 2023 to approve distribution of the 2022 net profit and of the RON0.03 per share gross dividend, reports to the...

Loredana Frățilă-Cristescu · 21.03.2023 · 00:00 · 1 min